Loading
Simulations Plus
Simulations Plus, Inc. develops drug discovery and development simulation software, which is licensed to and used in the conduct of drug research for pharmaceutical companies worldwide. The Company's other businesses are based on its proprietary software technologies and provide support for the emerging pharmaceutical enterprise.
Funding
Every round, secondary, debt facility or acquisition involving Simulations Plus that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—